Afrezza could breathe new life into inhaled insulin market
August 15, 2011Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news
New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …
Study shows new genetic risk factors for MS
August 15, 2011Research and Development genes, multiple sclerosis, research and development news
New genetic links to the immune system have been identified as a possible trigger for multiple sclerosis. The exact causes …
Ranbaxy closes down troubled liquid formulations plant
August 12, 2011Manufacturing and Production FDA, Ranbaxy, pharma manufacturing news, quality control
Indian drugmaker Ranbaxy Laboratories has decided to close down a manufacturing facility in the USA which has been under scrutiny …
GSK moves into diagnostics with Enigma
August 12, 2011Sales and Marketing Diagnostics, GSK, infectious diseases
GlaxoSmithKline has signed a deal to develop new tests with Enigma Diagnostics, extending a 2009 agreement with the Salisbury-based company. …
Online learning for non-medical prescribers launched
August 12, 2011Medical Communications Pfizer, Prescriber, medical education, non medical prescribing
Therapeutics PLUS, a free online medical education offering to healthcare professionals has been re-launched. The online resource has been created …
Pfizer pays compensation to Nigerian trial victims
August 12, 2011Kano, Pfizer, Trovan, misconduct, out of court
Pfizer has paid out the first compensation to families of children who died during a meningitis drug trial in Nigeria. …
Roche skin cancer drug approval ‘imminent’
August 11, 2011Sales and Marketing Roche, melanoma, vemurafenib
Skin cancer treatment Zelboraf looks set to gain FDA approval months ahead of schedule. Roche and Daiichi Sankyo’s drug is …
Janssen reaches partial agreement over criminal investigation
August 10, 2011Sales and Marketing Janssen, Risperdal, US, US Justice Department, illegal
Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …
TranslateMedia launches its new global translation platform, STREAM
August 10, 2011Global translation agency TranslateMedia is releasing a new version of its award-winning translation platform. The latest version – TranslateMedia STREAM …
Nanoparticles to target Alzheimer’s disease
August 10, 2011Research and Development Alzheimer's, nanoparticles
Researchers at Lancaster University funded by the European Union are hoping to develop a new treatment for Alzheimer’s disease. Nanoparticles …
New MS drug shows promise for Abbott
August 10, 2011Research and Development, Sales and Marketing Abbott, Avonex, Biogen, MS, gilenya
Biogen and Abbott’s multiple sclerosis drug daclizumab has performed well in a mid-stage trial, but two deaths marred the overall …
NICE wants more RoActemra data for juvenile idiopathic arthritis
August 9, 2011Medical Communications NICE, RoActemra, Roche
NICE has requested more evidence from Roche for RoActemra in childhood arthritis. RoActemra (tocilizumab) is being assessed for the treatment …
Shared API inspections project declared a success
August 9, 2011Manufacturing and Production API, EMA, FDA, TGA, pharma manufacturing news, regulatory inspections
A two-year facility inspection programme carried out by regulators in the USA, Europe and Australia has been deemed a success …
Taskforce to tackle £300m in wasted medicines
August 9, 2011Sales and Marketing Lord Howe, NHS, medinces management
A task force has been set up to tackle medicine wastage in the NHS – a problem which, the government …
Pfizer teams up with University of California for drug discovery
August 9, 2011Research and Development, Sales and Marketing Pfizer, academic research
Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme. The …
Investment firm adds Roche facility to growing portfolio
August 9, 2011Manufacturing and Production Colarado, International Chemical Investors, Roche, pharma manufacturing news
International Chemical Investors Group has snapped up another manufacturing facility, this time agreeing to buy a plant owned by Roche …
SkyePharma leases manufacturing business to CMO
August 9, 2011Manufacturing and Production Aenova, Skyepharma, pharma manufacturing news
German contract manufacturer Aenova is to lease a manufacturing unit near Lyon, France, from UK drugmaker SkyePharma. Aenova has taken …
Lonza profits slide as exchange rates bite
August 9, 2011Manufacturing and Production CMO, Lonza
A strong Swiss franc has pegged back first-half profits at fine chemical and contract manufacturer Lonza, although the company said …
Pradaxa approved for stroke prevention in Europe
August 9, 2011Sales and Marketing Pradaxa, atrial fibrillation, direct thrombin inhibitor
Boehringer Ingelheim’s Pradaxa has become the first drug in 50 years to be approved in Europe for stroke prevention in …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
